1[1]Lauer GM,Walker BD.Hepatitis C virus infection.N Engl J Med 2001; 345:41-52
2[2]Afdhal NH.The natural history of hepatitis C.Semin Liver Dis 2004; 24 Suppl 2:3-8
3[3]Manns MP,McHutchison JG,Gordon SC,Rustgi VK,Shiffman M,Reindollar R,Goodman ZD,Koury K,Ling M,Albrecht JK.Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C:a randomised trial.Lancet 2001; 358:958-965
4[4]Fried MW,Shiffman ML,Reddy KR,Smith C,Marinos G,Goncales FL Jr,Haussinger D,Diago M,Carosi G,Dhumeaux D,Craxi A,Lin A,Hoffman J,Yu J.Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.N Engl J Med 2002; 347:975-982
5[5]Guidotti LG,Chisari FV.Immunobiology and pathogenesis of viral hepatitis.Annu Rev Pathol 2006; 1:23-61
6[6]Lechner F,Wong DK,Dunbar PR,Chapman R,Chung RT,Dohrenwend P,Robbins G,Phillips R,Klenerman P,Walker BD.Analysis of successful immune responses in persons infected with hepatitis C virus.J Exp Med 2000; 191:1499-1512
7[7]Thimme R,Oldach D,Chang KM,Steiger C,Ray SC,Chisari FV.Determinants of viral clearance and persistence during acute hepatitis C virus infection.J Exp Med 2001; 194:1395-1406
8[8]Thimme R,Bukh J,Spangenberg HC,Wieland S,Pemberton J,Steiger C,Govindarajan S,Purcell RH,Chisari FV.Viral and immunological determinants of hepatitis C virus clearance,persistence,and disease.Proc Natl Acad Sci USA 2002; 99:15661-15668
9[9]Bertoletti A,Maini MK,Protection or damage:a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection? Curr Opin Immunol 2000; 12:403-408
10[10]Charo IF,Ransohoff RM.The many roles of chemokines and chemokine receptors in inflammation.N Engl J Med 2006; 354:610-621
